and Crossley, B.: Mechanisms of human tumor metastasis studied in 
patients with peritoneovenous shunts- Cancer Res. 44:3584-3592, 1984. 
32. Shu, S., Chou, T. and Rosenberg, S.A.: Generation from tumor-bearing 
mice of lymphocytes with in vivo therapeutic efficacy. J. Immunol. 
139:295-304, 1987. 
33. Chou, T., Chang, A. E . and Shu, S.: Generation of therapeutic T 
lymphocytes from tumor-bearing mice by in vitro sensitization. Culture 
requirements and characterization of immunologic specificity. J. 
Immunol . 140:2453-2461, 1988. 
34. Chou, T., Bertera, S., Chang, A.E. and Shu, S.: Adoptive immunotherapy 
of microscopic and advanced visceral metastases with in vitro sensitized 
lymphoid cells from mice bearing progressive tumors. J. Immunol. 
141:1775-1781, 1988. 
35. Shu, S., Chou, T., Rosenberg, S.A.: In vitro sensitization and expansion 
with viable tumor cells and interleukin-2 in the generation of specific 
therapeutic effector cells. J. Immunol. 136:3891, 1986. 
36. Miller, A.D. and Rosman, G. : Improved retroviral vectors for gene 
transfer and expression. Bio. Tech. 7:980-990, 1989. 
37. Miller, A.D. and Buttimore, C. : Redesign of retrovirus packaging cell 
lines to avoid recombination leading to helper virus production. Mol . 
Cell.. Biol. 6:2895-29002, 1986. 
38. Topalian, S.L., Kasid, A. and Rosenberg, S.A.: Immunoselection of a 
human melanoma resistant to specific lysis by autologous tumor 
infiltrating lymphocytes: Possible mechanisms for immunotherapeutic 
failures. J. Immunol. 144:4487-4495, 1990. 
39. Cornetta, K. and Anderson, W.F.: Protamine sulfate as an effective 
alternative to polybrene in retroviral-mediated gene transfer: 
Implications for human gene therapy. J. Virol. Meth. 23:186-194, 1989. 
40. Topalian, S.L., Muul, L.M., Solomon, D. and Rosenberg, S.A.: Expansion 
of human tumor infiltrating lymphocytes for use in immunotherapy trials. 
J. Immunol. Meth. 102:127-141, 1987. 
[98] 
Recombinant DNA Research, Volume 15 
